key: cord-0793210-epszma91
authors: Vincent, Alessia; Beck, Katharina; Becker, Christoph; Zumbrunn, Samuel; Ramin-Wright, Maja; Urben, Tabita; Quinto, Adrian; Schaefert, Rainer; Meinlschmidt, Gunther; Gaab, Jens; Reinhardt, Thomas; Bassetti, Stefano; Schuetz, Philipp; Hunziker, Sabina
title: Psychological burden in patients with COVID-19 and their relatives 90 days after hospitalization: A prospective observational cohort study
date: 2021-05-19
journal: J Psychosom Res
DOI: 10.1016/j.jpsychores.2021.110526
sha: 1d8dce2101093ac1d5723c26a4975b343dd6632b
doc_id: 793210
cord_uid: epszma91

Objective COVID-19 causes psychological distress for patients and their relatives at short term. However, little research addressed the longer-term psychological outcomes in this population. Therefore, we aimed to prospectively assess clinically relevant psychological distress in hospitalized patients with COVID-19 and their relatives 90 days after hospital discharge. Methods This exploratory, prospective, observational cohort study included consecutive adult patients hospitalized in two Swiss tertiary-care hospitals between March and June 2020 for confirmed COVID-19 and their relatives. The primary outcome was psychological distress defined as clinically relevant symptoms of anxiety and/or depression measured with the Hospital Anxiety and Depression Scale (HADS) 90 days after discharge. Results Clinically relevant psychological distress 90 days after hospital discharge was present in 23/108 patients (21.3%) and 22/120 relatives (18.3%). For patients, risk and protective factors associated with clinically relevant psychological distress included sociodemographic, illness-related, psychosocial, and hospital-related factors. A model including these factors showed good discrimination, with an area under the receiver-operating characteristic curve (AUC) of 0.84. For relatives, relevant risk factors were illness-related, psychosocial, and hospital-related factors. Resilience was negatively associated with anxiety and depression in both patients and relatives and regarding PTSD in relatives only. Conclusion COVID-19 is linked to clinically relevant psychological distress in a subgroup of patients and their relatives 90 days after hospitalization. If confirmed in an independent and larger patient cohort, knowledge about these potential risk and protective factors might help to develop preventive strategies.

The novel Coronavirus disease 2019 (COVID- 19) has caused a global pandemic with far-reaching consequences for many aspects of society, especially for patients diagnosed with COVID-19 and their relatives. While some patients have asymptomatic courses, many patients with COVID-19 experience a variety of symptoms or even develop an acute respiratory distress syndrome [1, 2] . Especially vulnerable individuals, patients above 65 years, patients with obesity, and people with chronic lung disease or cardiovascular comorbidities [3, 4] , may experience severe disease courses, requiring intensive care treatment and being linked to increased risk for persisting impairments or even mortality [5] [6] [7] . In addition to somatic morbidity, COVID-19 may also cause severe psychological distress. In fact, research during previous similar epidemics has shown that patients are at high risk for mental disorders, including depressive and anxiety disorders, post-traumatic stress disorder (PTSD), and sleep disorders [8] . Further, during previous pandemics, isolation measures similar to the ones currently used to contain COVID-19 have been associated with adverse psychological effects on patients and relatives [9] [10] [11] [12] .

Still, for COVID-19, there is currently a lack of studies investigating longer-term psychological sequelae of the disease in patients and their relatives. There is growing evidence that COVID-19 is linked to short-term psychological outcomes in patients, relatives as well as the general population [13] . For instance, a large Swiss survey of the general public found an increase in the prevalence of depressive symptoms from 3.4% before the pandemic to 9.1% during confinement and 11.7% during partial deconfinement [14] . Further, studies found prevalence rates of around 50% for psychological morbidities such as depression or anxiety in COVID-19 survivors [13, 15] .

Patients and relatives with insufficient knowledge of the local languages, cognitive impairment (i.e., a condition where patients were not able to understand and respond to the questions of our interview such as dementia or delirium), or serious psychiatric conditions (e.g., psychosis) were excluded. We did not apply any other exclusion criteria based on patient or COVID-19 related characteristics. We contacted patients and relatives by phone, informed them about our study and asked them to participate. To those who agreed, we sent a letter including the study information and informed consent form which they were asked to sign and return.

For this study, we conducted telephone interviews with each patients and relatives 30 days and 90 days after hospital discharge. In patients, we additionally reviewed medical charts and extracted clinical characteristics related to COVID-19. All other potential risk and protective factors were assessed at the 30-day "baseline" assessment. Primary and secondary outcomes, i.e., symptoms of anxiety, depression, and PTSD were assessed at the 90-day follow-up. To evaluate factors specific to the current pandemic, we used items designed for the purpose of this study. For all other predictive factors and all outcome variables, we conducted well-established clinical risk scores and validated psychometric measures.

We collected potential predictor variables adhering to four domains, i.e., sociodemographic, illness-related, psychological, and hospital-related.

J o u r n a l P r e -p r o o f Journal Pre-proof Sociodemographic factors were the same for both samples, but factors in the other three domains partially differed to account for patient-and relative-specific characteristics.

Sociodemographic factors in both patients and relatives included age, gender, citizenship, cultural background, religious affiliation, civil status, children, and current job situation.

In patients, illness-related factors included clinical parameters such as medication, i.e., investigational therapy, antibiotics, and anxiolytics during hospitalization, intensive care unit (ICU) stay, intubation, duration of hospitalization, and timepoint of COVID-19

diagnosis. Further, we assessed illness severity by the National Early Warning Score (NEWS) [18] , a widely used tool to detect patients at risk of clinical deterioration, and severity of comorbidity by the Charlson Comorbidity Index (CCI) [19] . Self-perceived overall health status was evaluated with the visual analogue scale (VAS) of the EuroQol, ranging from 0 (worst imaginable health) to 100 (best imaginable health) [20, 21] . In the domain of psychosocial factors, several psychological factors specific to the current pandemic were evaluated by items designed for the purpose of this study. In patients, these included worries caused by COVID-19 media reports, self-perceived stigma as scale (VAS) of 0-10. Additionally, we asked patients about pre-existing psychological comorbidities as well as frequency and kind of contact between them and their relatives.

Further, we assessed patients' perceived stress with the Perceived Stress Scale (10item version; PSS-10), a widely-used tool to evaluate how unforeseeable, uncontrollable and overwhelming respondents perceived their life during the last 30 days. [22, 23] . A study evaluating the psychometric properties of the PSS-10 in a representative sample of the German general population showed good internal consistency with a Cronbach alpha of 0.84 and good construct validity [24] . We determined resilience of patients through the 10-item version of the Connor-Davidson Resilience Scale (CD-RISC-10), indicating how well a person can cope with stress [25] . The CD-RISC is commonly used in clinical research and the original 25-item questionnaire as well as the 10-item version showed good validity with a Cronbach alpha of 0.89 and 0.88, respectively [25, 26] .

Further, the CD-RISC showed high test-retest reliability over a 12-month follow-up period [27] [28] [29] . Lastly, through items specifically designed for this study, we evaluated several hospital-related factors by a visual analogue scale of 0-10, i.e., perceived competence of treating physician, contradictory information given by medical team, burden of having no visitors, missing physical closeness and asked patients if the psychosocial care team was involved.

In relatives, in the domain of illness-related factors we assessed if they themselves were quarantined or infected with SARS-CoV-2, self-perceived overall health status (VAS of the EuroQol), the time point of the patient's COVID-19 diagnosis, as well if the patient had died. In alignment with patients' psychosocial variables, for relatives we also J o u r n a l P r e -p r o o f Journal Pre-proof evaluated potential risk and protective factors related to the current pandemic evaluated by items designed for this study. Items rated on a VAS of 0-10 included worries and burdens, i.e., worries due to COVID-19 media reports, perceived overall burden due to COVID-19, worries about uncertain prognosis, worries about infection, burden of isolation measures, burden of separation from patient, and other worries as well as helpfulness of coping strategies, i.e., social contacts, distraction, tranquilizers, alcohol consumption, relaxation techniques, sports, and other coping strategies. Additionally, we asked relatives how they were related to the patient, if they lived in the same household, about the frequency of contact with patient, pre-existing psychological comorbidities, psychological help, and intake of psychotropic drugs. Further, we assessed perceived stress (PSS-10) and resilience (CD-RISC-10). Hospital-related factors included contact and satisfaction with the medical team, if the relative received information regarding prognosis, comprehensibility of medical information, if medical care was perceived as sufficient or inadequate, if the relative received recommendations regarding own care, if the psychosocial care team was involved, burden of not being able to visit the patient, and missing physical closeness.

Primary and secondary outcome for both patients and relatives were assessed at 90day follow-up. The primary endpoint, psychological distress, defined as clinically relevant symptoms of anxiety and/or depression at the time of 90 days after discharge, was measured by the Hospital Anxiety and Depression Scale (HADS) [30] . This selfreport measure was developed for patient populations hospitalized with medical conditions and does not contain items on physical symptoms to avoid somatic J o u r n a l P r e -p r o o f confounding. A review on psychometric properties of the HADS revealed good reliability and validity with a Cronbach's alpha of 0.83 and 0.82 for the subscales anxiety and depression, respectively, and an optimal balance between sensitivity and specificity of approximately 0.80 when applying a cut-off score of ≥8 on both subscales. In line with previous research, a score of ≥8 on the depression and/or anxiety subscale (range: 0 to 21) of the HADS, indicating clinically relevant symptoms of depression and/or anxiety, was defined as clinically relevant psychological distress for the purpose of our study. [30, 31] .

The secondary outcome, i.e., symptoms of post-traumatic stress disorder, was assessed through a German translation of the Impact of Event Scale-revised (IES-R), which measures symptoms of emotional distress caused by traumatic events [32] . The IES-R is a 22-item questionnaire containing three subscales covering the three symptom domains intrusion, avoidance and hyperarousal. The IES-R has been shown to have high internal consistency with a Cronbach's alpha of 0.96 and good diagnostic accuracy when applying a cut-off score of 1.5 [33] , which we used to categorize participants regarding symptoms of PTSD.

Descriptive statistics, i.e. frequencies as well as means and standard deviations were used to present characteristics of the study population. Data from the patient and relative sample were analyzed separately. To investigate the associations of potential risk and protective factors assessed at 30-day follow-up and clinically relevant psychological distress at 90-day follow-up, we conducted univariable logistic regression models. We further conducted multivariable logistic regression models within the four J o u r n a l P r e -p r o o f domains, each including all significantly associated variables of the respective domain as well as the pre-defined variables age and gender in the patient sample and age, gender and death of patient in the relative sample. To investigate which variables might be independently associated, we additionally calculated a combined regression model including the pre-defined as well as all risk and protective factors associated with the outcome in univariable analyses. We show odds ratios (OR) and 95% confidence intervals (CI) as a measure of association and the area under the receiver operating characteristic curve (AUC) as a measure of discrimination. A p-value of <.05 (two-tailed) was considered statistically significant. All statistical analyses were conducted using Stata 15 (Stata Corp, College Station, Texas, USA).

Between March and June 2020, 301 patients with COVID-19 were hospitalized at the University Hospital of Basel (n=198) and Kantonsspital Aarau (n=103). Table 1 . Patients were on average 58 years old and 41.1% were female. The mean duration of hospitalization was nine days and 18 (16.8%) patients were J o u r n a l P r e -p r o o f transferred to the ICU with 11 (10.4%) requiring intubation. Relatives' mean age was 58 years, 79% were female, and they were mainly patients' spouses (52.1%). J o u r n a l P r e -p r o o f showed prevalence rates among newly recovered patients from 14% and 11% to 21% and 29% of anxiety and depression symptoms, respectively [34, 35] . Mazza et al.

evaluated Italian adults surviving COVID-19 one month after hospital discharge of which 31% reported clinically relevant depression and 42% anxiety symptoms [15] . In our follow-up, we found 21.3% of patients and 18.3% of relatives suffering from clinically relevant psychological distress. These short-term findings are comparable with our J o u r n a l P r e -p r o o f findings at three-months follow-up, which highlights the need to reduce these sequelae by better caring for patients and relatives [36] . Herein, we identified several potential targets. Whether preventive strategies help to reduce these risks, however, remains unclear and needs further research.

Interestingly, in our study the proportion of patients and relatives with clinically relevant psychological distress was similar to the proportion of patients reporting symptoms of anxiety. This is in line with a recent study reporting also high levels of anxiety and depression in both, isolated patients with COVID-19 and their relatives, during the initial stage of hospitalization [16] . Anxiety was also predominant in their analysis. Similarly, also other studies investigating relatives of patients with COVID-19

or other infections in the context of previous epidemics suggest that they suffer from higher levels of distress as compared to individuals of the general population [35, [37] [38] [39] [40] [41] . Importantly, we have learned that also the non-infected Swiss general population have an increase in depressive symptoms to up to 11.7% [14] . This suggests, that even though the pandemic has taken a toll on the mental well-being of all [39] [40] [41] , more attention should be paid to patients with COVID-19 and their relatives in order to develop strategies to prevent persistent adverse psychological outcomes [38, 42, 43] .

Several potential risk and protective factors could be identified in this study,

although not all of them are modifiable, but still may help to identify high risk subjects.

Some of these factors are known to be associated with psychological distress in general such as female gender, subjective health and resilience, while other factors such as the burden due to isolation measures or COVID-19 media reports are specific to the current pandemic.

Regarding the former category, we found that female patients were significantly more likely than males to suffer from clinically relevant psychological distress. In the general population, women are known to be more prone to depression and anxiety disorders [44] . Previous research also reported increased risk for anxiety and depression in women affected by COVID-19 [15, 16, 45] . Interestingly, gender of relatives and being in a relationship were not associated with psychological distress in relatives in our sample. Possibly, the current pandemic poses specific challenges on these relationships. Social support is a well-known protective factor regarding mental health, which has been affected by contact restrictions in COVID-19 patients. A review on the effects of quarantine measures during previous epidemics indicated a negative impact on psychological well-being of patients and relatives especially due to separation from partners and relatives [9] , which is in line with the findings of our study. While the majority of women tend to feel most emotionally supported by their friends, men usually report to mainly turn to their partner for emotional support [46, 47] . Thus, particularly male relatives may experience distress due to fear about the course of disease of the partner and the lack of emotional support. Still, further research re-evaluating our findings and conducting external validation of prediction models is needed. Also, rates of psychological distress often decline with increasing age overall [48] , and in COVID-19 [49, 50] . Still, there was no association of age and distress in our sample. As we focused our study to older, hospitalized patients, our study might have been biased in this regard.

Within the domain of illness-related factors, patients and relatives with lower subjective overall health status experienced increased psychological distress. Objective clinical parameters usually concomitant with psychological sequelae, e.g., high illness J o u r n a l P r e -p r o o f severity and hospitalization in the ICU [51] [52] [53] , however, were not associated. This might potentially be explained by the comparably small number of patients with severe illness course who needed intensive care treatment, i.e. 18 patients (16%) in our sample vs.

26% in a recent meta-analysis [54] . Several psychosocial factors were associated with clinically relevant psychological distress as expected and a combination of those showed high predictive value. Resilience, which can be defined as a person's emotional and mental capacity to adapt well when experiencing critical life events [55] [56] [57] , was negatively associated with anxiety and depression in both patients and relatives and with PTSD in relatives only. Resilience was not independently associated though and its association might be explained by other psychosocial characteristics and circumstances.

Based on our findings, availability of coping strategies such as exercise or social support through telephone and video calls as well as risk factors such as perceived stress or the overall burden due to COVID-19 might mediate the association between resilience and symptoms of anxiety, depression and PTSD. There is evidence indicating that resilience might be associated with poor mental health, e.g., symptoms of depression and anxiety in general [58] . Further, a review on resilience as a protective factor regarding symptoms of anxiety, depression and post-traumatic stress during the current pandemic found that many people use "resilient" coping strategies to handle COVID-19-related distress [59] . Exercise, which has a well-known positive effect on symptoms of depression and anxiety, emerged as a helpful coping strategy in relatives in our study.

Perceived stress, a widely-researched risk factor for symptoms of anxiety, depression and PTSD was associated with clinically relevant psychological distress in both patients and relatives. Future studies are needed to better understand how these factors are connected.

J o u r n a l P r e -p r o o f Further, we identified several potential risk and protective factors specific to COVID-19 that were associated with clinically relevant psychological distress in patients and relatives. Similar to other studies, overall burden due to COVID-19 was a relevant factor [14] . In addition, social connectedness did not significantly affect psychological distress in multivariable analyses beyond other psychosocial factors and its effect might therefore significantly vary depending on other characteristics and circumstances. The perceived burden of isolation measures, the burden of having no visitors or not being able to visit and missing physical contact were associated with clinically relevant psychological distress in patients and relatives. This again is in line with older studies

showing adverse psychological effects of quarantine and isolation [9, 16, 37] .

Particularly, physical distancing seems to be an important factor for psychological distress [60] . Bridging this gap between physical distancing and social connection might be possible with the help of digital technologies and more such interventions are urgently needed. However, our findings suggest that social connectedness may be considered in a larger context of several relevant interacting psychosocial factors.

Overall, of the factors associated with clinically relevant distress in our study, many are well-known risk and protective factors and some are specific to COVID-19.

This emphasizes the importance of not solely focusing on the negative impact of the COVID-19 pandemic and associated restrictions specifically but additionally considering the known characteristics that pose individuals at increased risk of developing significant psychological distress as well as the known protective factors and interventions that buffer the negative impact of stressful life events. Future research should further evaluate the role and interactions of known predictive factors and potential COVID-19 related risk factors. Insight into these dynamics might help to identify individuals who are J o u r n a l P r e -p r o o f at increased risk early on and to provide adequate support with the aim to prevent or mitigate mental health problems. Considering PTSD, one short-term follow-up study found a majority of inpatients with COVID-19 to report PTSD symptoms [61] , while another found a third of patients showing clinically relevant symptoms [15] . In our population, the lower rates of 7.8% and 7.1% for PTSD symptoms in patients and relatives, respectively, might be reflected by the later timepoint of our assessment. The higher rates found in the other studies [15, 61] might therefore display symptoms of acute stress remitting within one month after a traumatic event, of which only a minority develop a full PTSD [62] .

This study has some limitations. This two-center Swiss study was rather small and did not allow for rigorous statistical adjustment. Also, the observational design does not allow to draw any conclusions regarding preventive effects and the study is thus rather hypothesis generating. Due to the limited sample size, we did not have separate derivation and validation samples. Internal and external validation in independent and larger cohorts is therefore warranted. Further, the follow-up period of three months may have led to other factors leading to psychological distress and may confound findings as we did not have an unaffected control cohort at hand. Further, as the aim of this study was to assess a broad scope of potential risk and protective factors, multiple tests were conducted without statistical correction, to aid in an exploratory hypothesis generation.

However, a type I error cannot be ruled out and findings must, therefore, be considered exploratory and need validation. 

5%) showed symptoms of anxiety and ten (9.3%) symptoms of depression

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

The psychological effects of quarantining a city

Stress, coping and lessons learned from the SARS outbreak

Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: A systematic review and meta-analysis

The Swiss Corona Stress Study

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

Anxiety and Depression Symptoms in COVID-19 Isolated Patients and in Their Relatives

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Modeling valuations for EuroQol health states

EuroQol--a new facility for the measurement of health-related quality of life, Health policy

Psychometric analysis of the Ten-Item Perceived Stress Scale

A Global Measure of Perceived Stress

The German version of the Perceived Stress Scale -psychometric characteristics in a representative German community sample

Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC)

Measuring Resilience in Adult Women Using the 10-Items Connor-Davidson Resilience Scale (CD-RISC). Role of Trauma Exposure and Anxiety Disorders

Psychological factors predicting outcome after traumatic injury: the role of resilience

Erste Analyse der psychometrischen Eigenschaften und Struktur der deutschsprachigen 10-und 25-Item Version der Connor-Davidson Resilience Scale (CD-RISC)

The hospital anxiety and depression scale

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

Erfassung von psychischen Belastungsfolgen: Die Impact of Event Skala-revidierte Version

Psychometric properties of the Impact of Event Scale-Revised

Mental health status and related influencing factors of COVID-19 survivors in

The differential psychological distress of populations affected by the COVID-19 pandemic

Stress resilience during the coronavirus pandemic

Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic

Mental health of family, friends, and co-workers of COVID-19 patients in Japan

Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey

Psychological symptoms of ordinary Chinese citizens based on SCL-90 during the level I emergency response to COVID-19

Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

A 5-point strategy for improved connection with relatives of critically ill patients with COVID-19

Preloss grief in family members of COVID-19 patients: Recommendations for clinicians and researchers

World Health Organization, Gender disparities in mental health

Mental Health Status of Survivors Following COVID-19 in Wuhan, China: A Descriptive Study

Gender and marital-history differences in emotional and social loneliness among Dutch older adults

Gendered trajectories of support from close relationships from middle to late life

Identifying Predictors of Psychological Distress During COVID-19: A Machine Learning Approach

Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease

COVID-19: Understanding and mitigating trauma in ICU survivors

Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study

Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study

Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis

The science of resilience: implications for the prevention and treatment of depression

Neurobiology of resilience

Resilience and the brain: a key role for regulatory circuits linked to social stress and support

A meta-analysis of the trait resilience and mental health

Addressing psychological resilience during the coronavirus disease 2019 pandemic: a rapid review

The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention

Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China

American Psychiatric Association, Diagnostic and statistical manual of mental disorders (DSM-5®)

Declarations of competing interest: none.